Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma,British Journal of Surgery

当前位置： X-MOL 学术 › Br. J. Surg. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma
British Journal of Surgery ( IF 8.6 ) Pub Date : 2020-03-28 , DOI: 10.1002/bjs.11559
D. Wallace _{1,

2} , T. E. Cowling ₁ , K. Walker ₁ , A. Suddle ₂ , A. Gimson ₃ , I. Rowe _{4,

5} , C. Callaghan ₆ , G. Sapisochin _{7,

8} , N. Mehta ₉ , N. Heaton ₂ , J. van der Meulen ₁

Affiliation

Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) awaiting liver transplantation is widespread, although evidence that it improves outcomes is lacking and there exist concerns about morbidity. The impact of TACE on outcomes after transplantation was evaluated in this study.

中文翻译：